N/A N=353 Testing a Digital Intervention for Adolescents
Rumination · Stress, Psychological
Primary: Change in Perceived Stress [Perceived Stress Scale (PSS)] — 26.33; 25.26; 22.01; 24.67 score on a scale — p=<.001
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Early Phase 1 N=10 ICG and SLN Mapping
Breast Cancer
Primary: Concordance Between Detection of Sentinel Lymph Nodes by ICG Versus Technetium-99, at the Lymph Node Level — 100 percent concordance
N/A N=20 "Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program"
Dementia · Alzheimer's Disease · Dementia Prevention
Primary: Users' Engagement With the HALT-AD Online Platform by Measuring the Total Amount of Time (in Minutes) Spent Per User on All Courses Combined — 136 minutes
N/A N=47 Nutritional Intake of "Finger-food" on Elderly People in Seniors's Resident
Nutritive Value
Primary: Quantitative Measure of Ingesta — 941.1; 910.1; 1001; 862.9 Kilocalories — p=<0.0001
N/A N=206 FiO2 Closed Loop Control Ventilation
Wounds and Injuries · Respiratory Failure
Primary: Relative Duration With Oxygen Saturation (SpO2) Within Target Range [Time Frame: 12 Hours] — 0.53; 0.61 arbitrary units
N/A N=36 Acute Effect of MMT Peel Powder on Glycemic Response, Satiety, and Food Intake in Adults at Risk for Type 2 Diabetes
At Risk of Type 2 Diabetes Mellitus
Primary: Blood Glucose Levels — 5.6; 5.7; 6.7; 7.7 mmol/L — p=<0.001
N/A N=314 Reducing Cardiometabolic Risk and Promoting Functional Health in Older Adults With Obesity and Prediabetes
Obesity · PreDiabetes · Aging
Primary: Change in Bodyweight — -7.4; -6.1 percentage of bodyweight change — p=0.196
N/A N=247 Optimizing a Mobile Mindfulness Intervention for ICU Survivors
Cardiorespiratory Failure
Primary: Patient Health Questionnaire-9 Item Scale (PHQ-9) — 6.2; 6.4; 7.0; 5.6 units on a scale
N/A N=87 Motor Training in PD
Parkinson Disease
Primary: Percent Signal Change — 0; 23; 35 percentage of baseline BOLD signal
Early Phase 1 N=70 Wearable Monitoring Systems for Swallowing Function and Disorders
Deglutition Disorders
Primary: Normalized Task-related sEMG Amplitude (Signal Quality Parameter) — 12.5; 11.7; 17.3; 13.8 percentage of maximum amplitude — p=<0.025
Phase 4 N=536 Mail Order Mifepristone Study
Abortion Early · Pregnancy Related
Primary: Acceptability: Satisfaction With Mail-Order Dispensing of Medication Abortion — 452; 26; 7; 4 Number of abortions
Phase 4 N=23 Penicillin De-labeling in the Pediatric Primary Care Setting
Penicillin Allergy · Penicillin Reaction
Primary: Subjects Who Complete Risk-stratification of Penicillin Allergy in the Pediatric Primary Care Setting — 23 Participants
N/A N=49 TRANSLATE: Transgender and Gender Nonconforming Individuals' Access to Healthcare
Gender Identity
Primary: Change in Knowledge of TGNC Individuals of Total Number of Locations to Receive Medical Care in Cleveland Known — 3.79 locations
Phase 4 N=160 Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery
Postpartum Pain · Postpartum Depression · Opioid Consumption
Primary: Opioid Consumption in MME — 0; 0 MME
Phase 2 N=32 Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer
Pancreatic Cancer
Primary: Overall Survival — 9.5; 10.1 Median months subjects survived